+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032- Product Image
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032- Product Image
New

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127172
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI-driven peptide drug discovery platforms are reshaping the way therapeutics are designed, offering biopharma organizations integrated tools to accelerate candidate selection and operational efficiency. Decision-makers across the life science sector are prioritizing solutions that enable faster translation from computational hypothesis to laboratory validation.

Market Snapshot: AI-driven Peptide Drug Discovery Platform Market

The AI-driven Peptide Drug Discovery Platform Market grew from USD 1.08 billion in 2025 to USD 1.21 billion in 2026 and is projected to increase at a CAGR of 12.29%, reaching USD 2.44 billion by 2032. This growth reflects strong adoption among leading pharmaceutical, biotechnology, and research organizations as they seek to enhance discovery pipelines, optimize workflows, and improve the developability of novel peptide therapeutics.

Scope & Segmentation

This report examines the drivers, barriers, and strategic choices shaping the global market for AI-driven peptide drug discovery platforms. Detailed segmentation enables targeted insights for buyers, vendors, and partners in this field.

  • Platform Models: Software solutions, integrated discovery services, and hybrid offerings.
  • Discovery Stages: Target identification, hit discovery, lead optimization, developability assessment.
  • Enabling Technologies: Machine learning, deep learning, generative modeling, physics-informed approaches, automated laboratory integration.
  • End User Types: Pharmaceutical firms, biotechnology companies, academic/research institutes, contract research and development organizations.
  • Peptide Formats: Linear, cyclic, stapled, conjugated peptides, with guidance for addressing unique format and developability challenges.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—encompassing local regulatory, infrastructure, and collaboration factors.

Key Takeaways

  • AI-driven peptide discovery is advancing from augmenting traditional workflows to providing multi-objective design, balancing therapeutic efficacy, safety, and manufacturability within a single, integrated platform.
  • Closed-loop experimentation, where real-world assay results iteratively refine model predictions, is enabling more informed and translatable candidate selection.
  • Expanding peptide modalities—including macrocyclic and stapled formats—are driving demand for advanced physics-aware modeling and developability prediction to avoid late-stage failures.
  • Modern platforms increasingly adopt data-centric models, emphasizing curated experimental repositories, reproducible workflows, and interoperability with ELN and LIMS systems.
  • Strategic partnerships are facilitating access to high-quality synthesis, diverse datasets, and robust governance structures, supporting both data integrity and operational resilience.
  • Translational outcomes, rather than algorithmic novelty, now define platform value; buyers prioritize measurable improvements in cycle time, candidate quality, and manufacturability.

Tariff Impact: Navigating U.S. Supply Chain Pressures

Anticipated United States tariffs in 2025 are increasing the cost and complexity of procuring peptide synthesis consumables, specialty reagents, and laboratory equipment. Although these platforms are digitally driven, supply chain friction affects the cadence and cost-efficiency of laboratory validation. In response, platform vendors and life sciences organizations are emphasizing dual sourcing, tariff-aware design, and local partnerships to ensure continuity of experimentation. This trend favors platforms that can adapt experimental designs in real time and maintain consistent integration with domestic suppliers and CRO/CDMOs.

Methodology & Data Sources

This assessment draws on both primary and secondary research. Insightful interviews with stakeholders across discovery science, translational research, and procurement form the foundation, complemented by analysis of peer-reviewed publications, patent filings, regulatory guidance, and market disclosures. Triangulation ensures robustness, while feature mapping and segmentation synthesize evolving needs and best practices.

Why This Report Matters

  • Presents an actionable overview linking AI capability to operational impact, aligning technical selection with business objectives.
  • Clarifies how segmentation by user, stage, and region shapes platform strategy and adoption pathways.
  • Details real-world barriers and success factors, enabling senior leaders to anticipate risks from supply chain volatility and regulatory trends.

Conclusion

The AI-driven peptide drug discovery sector is maturing toward outcome-focused, resilient innovation. Leaders well-positioned for success will integrate robust data, manufacturability, and closed-loop delivery as fundamental platform features.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. AI-driven Peptide Drug Discovery Platform Market, by Technology Type
8.1. Cloud Based Platform
8.1.1. Hybrid Cloud
8.1.2. Private Cloud
8.1.3. Public Cloud
8.2. Deep Learning Platform
8.2.1. Convolutional Neural Network
8.2.2. Graph Neural Network
8.2.3. Recurrent Neural Network
8.3. Machine Learning Platform
8.3.1. Reinforcement Learning
8.3.2. Supervised Learning
8.3.3. Unsupervised Learning
8.4. On Premise Platform
8.4.1. Conventional Hpc
8.4.2. Dedicated Servers
9. AI-driven Peptide Drug Discovery Platform Market, by Therapeutic Application
9.1. Cardiovascular
9.1.1. Atherosclerosis
9.1.2. Heart Failure
9.2. Infectious Diseases
9.2.1. Bacterial
9.2.2. Viral
9.3. Metabolic Disorders
9.3.1. Diabetes
9.3.2. Obesity
9.4. Neurological
9.4.1. Alzheimers
9.4.2. Parkinsons
9.5. Oncology
9.5.1. Hematological Malignancies
9.5.2. Solid Tumors
10. AI-driven Peptide Drug Discovery Platform Market, by Peptide Class
10.1. Cyclic Peptides
10.1.1. Head To Tail
10.1.2. Side Chain To Side Chain
10.2. Linear Peptides
10.2.1. Long Peptides
10.2.2. Short Peptides
10.3. Peptidomimetics
10.3.1. Beta Peptides
10.3.2. Peptoids
11. AI-driven Peptide Drug Discovery Platform Market, by End User
11.1. Academic & Government Research Institutes
11.1.1. Private Research Institutes
11.1.2. Public Research Institutes
11.2. Contract Research Organizations
11.2.1. Large Cro Organizations
11.2.2. Small Cro Organizations
11.3. Pharmaceutical & Biotechnology Companies
11.3.1. Biotechnology Companies
11.3.2. Pharmaceutical Companies
12. AI-driven Peptide Drug Discovery Platform Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. AI-driven Peptide Drug Discovery Platform Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. AI-driven Peptide Drug Discovery Platform Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States AI-driven Peptide Drug Discovery Platform Market
16. China AI-driven Peptide Drug Discovery Platform Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Atombeat, Inc.
17.6. Aurigene Discovery Technologies Limited
17.7. Cradle, Inc.
17.8. Creative Peptides, Inc.
17.9. Deep Genomics Inc.
17.10. DenovAI Biotech, Inc.
17.11. Fujitsu Limited
17.12. Generate Biomedicines, Inc.
17.13. Gubra ApS
17.14. Iktos SA
17.15. Insilico Medicine, Inc.
17.16. Koliber Biosciences, Inc.
17.17. Numerion Labs, Inc.
17.18. Nuritas Limited
17.19. Pepticom, Inc.
17.20. Peptilogics, Inc.
17.21. Relay Therapeutics, Inc.
17.22. Space Peptides, Inc.
List of Figures
FIGURE 1. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GRAPH NEURAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GRAPH NEURAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY GRAPH NEURAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REINFORCEMENT LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REINFORCEMENT LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY UNSUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY UNSUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVENTIONAL HPC, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVENTIONAL HPC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONVENTIONAL HPC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEDICATED SERVERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEDICATED SERVERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEDICATED SERVERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY OBESITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY OBESITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ALZHEIMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ALZHEIMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ALZHEIMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PARKINSONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PARKINSONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEAD TO TAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEAD TO TAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY HEAD TO TAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SIDE CHAIN TO SIDE CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SIDE CHAIN TO SIDE CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SIDE CHAIN TO SIDE CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LONG PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LONG PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LONG PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SHORT PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SHORT PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SHORT PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BETA PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BETA PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BETA PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LARGE CRO ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LARGE CRO ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LARGE CRO ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SMALL CRO ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SMALL CRO ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SMALL CRO ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY NEUROLOGICAL, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDE CLASS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CYCLIC PEPTIDES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY LINEAR PEPTIDES, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PEPTIDOMIMETICS, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 246. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 248. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CLOUD BASED PLATFORM, 2018-2032 (USD MILLION)
TABLE 249. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY DEEP LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 250. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY MACHINE LEARNING PLATFORM, 2018-2032 (USD MILLION)
TABLE 251. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY ON PREMISE PLATFORM, 2018-2032 (USD MILLION)
TABLE 252. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 254. EUROPE AI-DRIVEN PEPTIDE DRUG DISCOVERY PLATFORM MARKET SIZE, BY INFECTI

Companies Mentioned

The key companies profiled in this AI-driven Peptide Drug Discovery Platform market report include:
  • Atombeat, Inc.
  • Aurigene Discovery Technologies Limited
  • Cradle, Inc.
  • Creative Peptides, Inc.
  • Deep Genomics Inc.
  • DenovAI Biotech, Inc.
  • Fujitsu Limited
  • Generate Biomedicines, Inc.
  • Gubra ApS
  • Iktos SA
  • Insilico Medicine, Inc.
  • Koliber Biosciences, Inc.
  • Numerion Labs, Inc.
  • Nuritas Limited
  • Pepticom, Inc.
  • Peptilogics, Inc.
  • Relay Therapeutics, Inc.
  • Space Peptides, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.21 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.44 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
mRNA Vaccine Drugs Development Services Market - Global Forecast 2026-2032 - Product Image

mRNA Vaccine Drugs Development Services Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2025 - Product Image

G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.